Comparison of Antidiabetic Agent Prescribed Medications: Oral Medicines and Insulin, 1997 and 2003. Statisitcal Brief Number 118

摘要

This Statistical Brief compares 1997 and 2003 data for the U.S. civilian noninstitutionalized (community) population from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC) on the total expenditures, total number of purchases, and number of people with purchases of prescribed antidiabetic medicines. In addition to the larger therapeutic subclass of prescribed antidiabetic agents, similar trend data are provided for two smaller groupings of prescribed medications that comprise the subclass of antidiabetic agents: insulin (which is an injectable) and oral antidiabetic medicines (which include sulfonylureas, nonsulfonylureas, alpha glucosidase inhibitors, thiazolidinediones, meglitinides, and antidiabetic combinations). All differences discussed in the text are statistically significant at the 0.05 level. Expenditures are in nominal dollars.